CLMHT-01 is under development for the treatment of hypertension. It is a single label combination product in development, linking Closed Loop Medicine’s proprietary software as a medical device (SaMD) ...

Dublin, Oct. 31, 2024 (GLOBE NEWSWIRE) -- The "Precision Medicine Software Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Precision Medicine ...

Additionally, the push towards personalized medicine creates opportunities for developing software that can adapt to individual patient data and contribute to customized treatment plans.

Scipher will contribute data derived from its PrismRA blood test to the Atropos Evidence Network, which underpins software tools, including an AI chatbot.